Zealand Pharma A/S
(LTS:0NZU)
kr
951.25
11.75 (1.28%)
Market Cap: 65.60 Bil
Enterprise Value: 63.98 Bil
PE Ratio: 0
PB Ratio: 20.38
GF Score: 66/100 - Q1 2024 Zealand Pharma A/S Earnings Call TranscriptMay 16, 2024kr619.25 (-4.22%)Earnings
- Full Year 2023 Zealand Pharma A/S Earnings Call TranscriptFeb 27, 2024kr617.75 (-5.07%)Earnings
- Zealand Pharma A/S at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Zealand Pharma A/S Obesity R&D Event TranscriptDec 05, 2023
- Q3 2023 Zealand Pharma A/S Earnings Call TranscriptNov 09, 2023kr302.5 (+3.88%)Earnings
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Zealand Pharma A/S Earnings Call TranscriptAug 17, 2023kr241 (+5.01%)Earnings
- Zealand Pharma A/S at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Zealand Pharma A/S at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Zealand Pharma A/S Earnings Call TranscriptMay 11, 2023kr241 (+10.65%)Earnings
- Zealand Pharma A/S at Needham Healthcare Conference (Virtual) TranscriptApr 19, 2023
- Zealand Pharma A/S Annual Shareholders Meeting TranscriptMar 29, 2023
- Q4 2022 Zealand Pharma A/S Earnings Call TranscriptMar 02, 2023kr228.1 (+5.31%)Earnings
- Zealand Pharma A/S at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Zealand Pharma A/S Earnings Call TranscriptNov 10, 2022kr188.4 (-1.80%)Earnings
- Zealand Pharma A/S Corporate Call TranscriptSep 30, 2022
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Zealand Pharma A/S Earnings Call TranscriptAug 11, 2022kr130.95 (+7.29%)Earnings
- Q1 2022 Zealand Pharma A/S Earnings Call TranscriptMay 12, 2022kr73.63 (-5.21%)Earnings
- Zealand Pharma A/S at Needham Healthcare Conference (Virtual) TranscriptApr 11, 2022
- Zealand Pharma A/S Corporate Update Call TranscriptMar 30, 2022
- Q4 2021 Zealand Pharma A/S Earnings Call TranscriptMar 10, 2022kr91.18 (+1.25%)Earnings
- Q3 2021 Zealand Pharma A/S Earnings Call TranscriptNov 11, 2021kr176.6 (-11.28%)Earnings
- Zealand Pharma A/S at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Zealand Pharma A/S Earnings Call TranscriptAug 12, 2021kr177.6 (-1.66%)Earnings
- Zealand Pharma A/S at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Q1 2021 Zealand Pharma A/S Earnings Call TranscriptMay 12, 2021kr181.7 (-2.91%)Earnings
- Zealand Pharma A/S Corporate Call TranscriptMar 23, 2021
- Full Year 2020 Zealand Pharma A/S Earnings Call TranscriptMar 11, 2021kr198.5 (+0.51%)Earnings
- Zealand Pharma A/S - Special Call TranscriptMar 05, 2021
- Zealand Pharma A/S - Pre Recorded Special Call TranscriptMar 04, 2021
- Q3 2020 Zealand Pharma A/S Earnings Call TranscriptNov 12, 2020kr232.8 (-2.88%)Earnings
- Zealand Pharma A/S Presents at Morgan Stanley 18th Annual Global Healthcare Conference, Sep-14-2020 10:30 AM TranscriptSep 14, 2020
- Q2 2020 Zealand Pharma A/S Earnings Call TranscriptAug 13, 2020kr238.7 (+4.28%)Earnings
- Q1 2020 Zealand Pharma A/S Earnings Call TranscriptMay 14, 2020kr236.5 (-6.71%)Earnings
- Zealand Pharma A/S at Needham Healthcare Conference TranscriptApr 15, 2020
- Zealand Pharma A/S Annual Shareholders Meeting TranscriptApr 02, 2020
- Full Year 2019 Zealand Pharma A/S Earnings Call TranscriptMar 12, 2020kr170.05 (-20.20%)Earnings
- Valeritas Holdings, Inc., Zealand Pharma A/S - M&A Call TranscriptFeb 10, 2020
- Q3 2019 Zealand Pharma A/S Earnings Call TranscriptNov 14, 2019kr222.5 (+3.01%)Earnings
- Zealand Pharma A/S Expands Its Peptide Platform with Acquisition of Encycle Therapeutics Inc Call TranscriptOct 22, 2019
- Half Year 2019 Zealand Pharma A/S Earnings Call TranscriptAug 15, 2019kr147.65 (-1.44%)Earnings
- Q1 2019 Zealand Pharma A/S Earnings Call TranscriptMay 16, 2019kr136 (+0.18%)Earnings
- Zealand Pharma A/S - Special Call TranscriptMar 21, 2019
- Q4 2018 Zealand Pharma A/S Earnings Call TranscriptMar 07, 2019kr97.8 (-2.93%)Earnings
Zealand Pharma A/S at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 10, 2021 / 01:40PM GMT
Release Date Price:
kr193.2
(+3.12%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay. Good morning, everyone, and welcome to the 9:40 session on day 3 of the 42nd Annual Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover European and U.S. biopharma names here at the firm. It's my great pleasure to be hosting Zealand Pharma in a fireside chat discussion today. And with us is Emmanuel Dulac, who is CEO of the company; and Matt Dallas, CFO of the company as well. And so with that, Emmanuel and Matt, welcome.
Matthew Donald Dallas;S;Senior VP;CFO
Zealand Pharma A
/-&
Thanks, Graig.
Emmanuel Dulac;S;CEO;President
Zealand Pharma A
/-&
Thank you, Graig.
Questions & Answers
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)